Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets (Parenthetical)

v3.21.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Accounts receivable allowance, net $ 235 $ 646
Preferred stock, par value (in usd per share) $ 0.001  
Preferred stock, shares authorized (in shares) 5,000,000  
Common stock, par value (in usd per share) $ 0.001  
Common stock, shares authorized (in shares) 250,000,000  
Common stock, shares issued (in shares) 53,178,462 4,234,923
Common stock, shares outstanding (in shares) 53,178,461 4,234,922
Treasury stock (in shares) 1 1
Accumulated deficit reclassified to additional paid in capital in quasi-reorganization $ 2,442  
Series 4 Convertible Preferred Stock    
Preferred stock, shares authorized (in shares) 10,415 10,415
Preferred stock, shares issued (in shares) 1 1
Preferred stock, shares outstanding (in shares) 1 1
Series 5 Convertible Preferred Stock    
Preferred stock, shares authorized (in shares) 12,000 12,000
Preferred stock, shares issued (in shares) 126 0
Preferred stock, shares outstanding (in shares) 126 0